The effects of maternal and infant vitamin A supplementation on vitamin A status: a randomised trial in Kenya

British Journal of Nutrition
Q1
Aug 2007
Citations:43
Influential Citations:4
Interventional (Human) Studies
87
S2 IconPDF Icon

Enhanced Details

Methods
Randomised, placebo-controlled, double-blind trial conducted in rural western Kenya (Bondo District) from 1999–2001. 564 pregnant women (<24 weeks gestation) with live singleton births and their infants were enrolled and randomized to maternal vitamin A or placebo at delivery, and infants to infant vitamin A or placebo at 14 weeks. Outcomes included maternal serum retinol (14 and 26 weeks postpartum), milk retinol (4, 14, 26 weeks), infant serum retinol (14 and 26 weeks) and MRDR at 26 weeks.
Intervention
Maternal: 400,000 IU vitamin A given orally within 24 hours of delivery (two 200,000 IU capsules). Infant: 100,000 IU vitamin A given orally at 14 weeks of age (vs placebo).
Results
Maternal postpartum high-dose vitamin A did not increase maternal serum retinol or infant serum retinol or MRDR; it modestly increased milk retinol at early postpartum time points (week 4, with higher values per volume and per fat at week 4). Infant vitamin A supplementation at 14 weeks increased infant vitamin A stores as shown by MRDR at 26 weeks (mean MRDR ratio −0.012; 95% CI −0.019, −0.005); the proportion of infants with high MRDR (>0.06) tended to decrease with infant supplementation (OR 0.66; 95% CI 0.41–1.05; P=0.08), though not statistically significant. No interaction between maternal and infant supplementation was detected. Conclusion: Infants benefit from 100,000 IU vitamin A at 14 weeks by improved vitamin A stores; maternal supplementation alone showed limited impact on status. Factors affecting absorption/metabolism may modify responses; guidelines should emphasize demonstrated morbidity/mortality benefits rather than status alone.
Limitations
Incomplete data for several outcomes (milk retinol measured in about 71–75% of participants; MRDR measured in about 64% of infants); HIV status not assessed; potential acute-phase effects and other unmeasured factors influencing vitamin A absorption/metabolism.

Abstract

Postpartum vitamin A supplementation of mothers and infants is recommended, but the efficacy has been questioned. In this double-blind, placebo-controlled trial, Kenyan mother–infant pairs were randomised to maternal vitamin A (400 000 IU) or placebo...